Article
Polypharmacy and Frailty among Hemodialysis Patients.
Nephron - 1 Jan 2021
Kimura Hiroshi, Kalantar-Zadeh Kamyar, Rhee Connie M, Streja Elani, Sy John
Abstract excerpt
BACKGROUND: Both polypharmacy and frailty are highly prevalent among the patients on hemodialysis and associated with adverse outcomes; however, little is known about the association between them. METHODS: We examined 337 patients enrolled in the ACTIVE/ADIPOSE dialysis cohort study between 2009 and 2011. The number of prescribed medications and frailty were assessed at baseline, 12, and 24 months. Frailty was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
